What is MedeAnalytics?
MedeAnalytics operates at the intersection of healthcare informatics and enterprise software. As a first-to-market innovator in healthcare analytics since 1993, the company provides a sophisticated SaaS platform that empowers health systems to derive actionable insights from complex datasets. By integrating machine learning, guided analysis, and predictive modeling, MedeAnalytics enables organizations to optimize operational efficiency and clinical performance. Furthermore, its platform-as-a-service offering allows clients to develop bespoke applications, positioning the company as an essential infrastructure partner for modern, data-centric healthcare institutions.
How much funding has MedeAnalytics raised?
MedeAnalytics has raised a total of $57M across 2 funding rounds:
Other Financing Round
$7M
Series C
$50M
Other Financing Round (2004): $7M with participation from Kennet Partners
Series C (2008): $50M led by Bain Capital Ventures
Key Investors in MedeAnalytics
Kennet Partners
Kennet is a transatlantic growth equity firm that invests in established, high-growth, founder-led technology companies in Europe and North America, focusing on capital-efficient B2B software.
Bain Capital Ventures
Bain Capital is a leading global private investment firm that applies deep sector expertise and broad capabilities to drive innovation in investment strategies and unlock exceptional outcomes.
What's next for MedeAnalytics?
Looking ahead, MedeAnalytics is poised to capitalize on the increasing demand for interoperable healthcare data solutions. The strategic deployment of $0 will likely focus on deepening the integration of artificial intelligence within its core product offerings, ensuring that clients can navigate the complexities of value-based care with greater precision. As the healthcare industry continues to prioritize digital transformation, MedeAnalytics is well-positioned to maintain its competitive edge by scaling its platform capabilities and expanding its footprint in both domestic and international markets. The firm's focus on capital-efficient growth and technological innovation remains the primary driver for its long-term value creation strategy.
See full MedeAnalytics company page
